Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-038587
Filing Date
2025-08-07
Accepted
2025-08-07 07:11:58
Documents
66
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cccc-20250630.htm   iXBRL 10-Q 1420529
2 EX-31.1 cccc-20250630xexx311.htm EX-31.1 10209
3 EX-31.2 cccc-20250630xexx312.htm EX-31.2 10255
4 EX-32.1 cccc-20250630xexx321.htm EX-32.1 4675
5 EX-32.2 cccc-20250630xexx322.htm EX-32.2 4686
  Complete submission text file 0001628280-25-038587.txt   6350858

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20250630.xsd EX-101.SCH 42408
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cccc-20250630_cal.xml EX-101.CAL 67772
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cccc-20250630_def.xml EX-101.DEF 187066
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20250630_lab.xml EX-101.LAB 535769
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20250630_pre.xml EX-101.PRE 355385
69 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20250630_htm.xml XML 807991
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39567 | Film No.: 251191564
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)